InvestorsHub Logo
icon url

The Night Stalker

12/14/19 1:43 PM

#1733 RE: Laylos #1732

no T trade on friday, trade clean for a few days, volume will spark again , they hinted news before year end
icon url

The Night Stalker

12/15/19 5:36 PM

#1744 RE: Laylos #1732


Ozop Surgical Corp. Announces an Update to the Exclusive License Agreement with Spinal Resources Inc. for Spinal Implants
Press Release | 10/16/2019
Revenue ramp-up underway with pathway to operating profit

WEST PALM BEACH, FL, Oct. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium surgical devices in the rapidly growing field of minimally invasive spine surgery (“Ozop” or the “Company”), today released the following corporate update on its recent progress and current developments. Ozop believes the license agreement with Spinal Resources, Inc. is exceeding Company expectations.

Some of the specific developments include:

· 3 new surgeons currently using its licensed products, with 2 more expected to schedule cases before year end.

· 2 new Distributors in the contract finalization stage, ramp up expected to start by year end.

· 3 hospital contracts, including one national agreement, in the finalization stage. Cases starting upon approval possibly as soon as December.

· 3 new product introductions, the first, a proprietary MIS system before the end of year.

· First member of its surgeon advisory board has joined, more updates to follow.

Michael Chermak, Chief Executive Officer of OZOP, commented, “Our primary objective is to achieve operational profitability at the earliest moment possible. Our path to this goal will be accomplished by a combination of maximizing current sales opportunities and reducing overhead wherever possible, and investing in inventory and product development to support our growing sales pipeline.”

About Ozop Surgical Corp.
icon url

The Night Stalker

12/15/19 5:37 PM

#1745 RE: Laylos #1732

lets see news happen
icon url

The Night Stalker

12/15/19 5:44 PM

#1746 RE: Laylos #1732

past 8ks minimal dilution, over time 50k note, 66k note and last note dated september priced at 01 , the Actus note 250k matures in october 18 2020